ADVANCES IN OUR UNDERSTANDING OF THE EXTENT and regulation of adult neurogenesis have been dependent on continued improvements in the detection and quantification of critical events in neurogenesis. To date, no specific and exclusive stem cell marker has been described that would allow for prospective studies of neurogenesis. As a result, detection of neurogenic events has depended on a combination of labeling approaches that document the two critical events in neurogenesis: the generation of new cells and their subsequent progression through lineage commitment to a mature neuron.
ADVANCES IN OUR UNDERSTANDING OF THE EXTENT and regulation of adult neurogenesis have been dependent on continued improvements in the detection and quantification of critical events in neurogenesis. To date, no specific and exclusive stem cell marker has been described that would allow for prospective studies of neurogenesis. As a result, detection of neurogenic events has depended on a combination of labeling approaches that document the two critical events in neurogenesis: the generation of new cells and their subsequent progression through lineage commitment to a mature neuron.
Detection of neurogenesis in vivo requires the ability to image at a cellular resolution. Although advances in noninvasive imaging approaches, such as magnetic resonance imaging (MRI), show promise for longitudinal studies of neurogenesis, the lack of suitable resolution to characterize individual cells limits the information that can be obtained. In vivo microscopy, using deeply penetrating UV illumination with mulitphoton microscopy or by the recently available endoscopic confocal microscopy, may provide new opportunities for longitudinal studies of neurogenesis in the living animal with single-cell resolution. These latter microscopy approaches are particularly compelling when coupled with transgenic mice expressing phenotype-specific fluorescent reporter genes. However, at present, the predominant approach for studies of neurogenesis relies on traditional histological methods of fixation, production of tissue sections, staining, and microscopic analysis.
This chapter discusses methodological considerations for in vivo detection of neurogenesis in the adult brain according to our current state of knowledge. First, detection of newly generated cells is evaluated and the strengths of using exogenous or endogenous markers of the cell cycle are discussed. Next, the individual phenotype markers that contribute to resolving stages of neuronal lineage commitment and their value in combinatorial staining are addressed. The accurate analysis of the cell phenotype is subject to a number of potential artifacts. These potential pitfalls are elaborated along with suggestions for accurate detection and reliable quantification of cell number. Neurogenesis is modulated by many environmental variables, and accurate detection combined with a precise readout of changes in cell number is critical for reliable data in studies of neurogenesis.
CELL CYCLE PROGRESSION Thymidine Analogs as Exogenous Markers of DNA Replication
Stem cells are defined by their ability to self-renew and the capacity of their progeny to adopt multiple lineages. In addition to self-renewal, expansion of progenitor populations by repeated entry into the cell cycle is a fundamental feature of neurogenesis. As a result, analysis of cell cycle activity is a critical component of neurogenesis studies. The cell cycle (Fig. 1A) consists of a sequence of distinct stages. DNA replication during the S phase of the cell cycle has been utilized as an opportunity to birth-date proliferating cells by supplying a thymidine analog that can be incorporated into the cell (Fig. 1B) . The thymidine analog is retained in the postmitotic cell, permitting a cohort of dividing cells, labeled at a known time, to be subsequently detected.
The ability to label a cohort of dividing cells has provided a useful tool to assess the existence of adult neurogenesis and changes in neurogenesis under different conditions. The original approach to detect incorporation of [ deposition of silver grains in combination with immunoperoxidase labeling for phenotypic markers due to their overlap in the cell obscuring visualization. A second methodological concern is that the thin sections needed for an autoradiographic study limit the use of stereological quantitation. The mitotic cell cycle consists of the regulated transition of a cell through the sequential phases of G 1 , S, G 2 , and M from which the cell can remain postmitotic or reenter cell cycle again. (B) DNA replication occurs during S phase (synthesis), and this essential step of the cell cycle can be detected by the availability of thymidine analogs that are incorporated during DNA replication and can be subsequently detected by immunocytochemistry. Thymidine analogs allow birth-dating as they define the time of incorporation, but they do not discriminate subsequent phases of cell cycle (illustrated by the tail extending on into G 2 and M). DNA replication can be probed again to determine if a labeled cell has again reentered cell cycle pairing with either [ 3 H]thymidine and bromodeoxyuridine (BrdU) or chlorodeoxyuridine (CldU) and iododeoxyuridine (IdU). (C) Endogenous cell cycle proteins are expressed at different stages of cell cycle progression, and their expression offers a tool to examine regulation of cell cycle progression. Some of these, such as Cdk1 and proliferating cell nuclear antigen (PCNA), are broadly expressed thoughout the cell cycle and thus provide low temporal resolution about specific cell cycle progression. Ki-67 closely corresponds to thymidine analog detection as it is expressed both during S phase and through the remainder of the cell cycle. More specific temporal resolution is offered by phosphohistone H3 (pHisH3) which is only expressed following S phase.
Both of these drawbacks have been overcome through the use of the thymidine analog bromodeoxyuridine (BrdU). Like [ 3 H]thymidine, BrdU is incorporated during DNA replication, but its presence in the nucleus can be detected by immunohistochemistry, permitting single labeling or multiple labeling with phenotypic markers detected by bright-field or fluorescence microscopy. As thicker sections can be used, detection of BrdU by immunohistochemistry is suitable for design-based stereological quantification. Thymidine analogs are used in most study designs of in vivo neurogenesis. Table 1 presents a summary of study design considerations.
Although BrdU administration provides the opportunity to birth-date a cohort of proliferating cells and to study their fate at a later date, this approach is of limited temporal resolution with respect to both uptake and detection. There is no evidence that cells in the adult dentate gyrus (DG) or subventricular zone are synchronized with respect to their proliferative state. Thus, administration of BrdU will label a distribution of cells in S phase where any individual cell may completely or only partial overlap the availability of BrdU in tissue. In addition, once incorporated, the presence of BrdU does not discriminate between the cells' subsequent replicative states. As a result, additional cell cycle activity in a BrdU-labeled cell would not be detected. Early studies in the field of adult neurogenesis did not fully account for these considerations and tended to adopt a BrdU administration paradigm which ensured that an adequate population would be labeled to facilitate analysis. In recent years, it has become evident that such broad study designs, with BrdU given for days or weeks, severely limited the ability to discriminate between proliferation and survival of newly generated cells. Therefore, current studies typically have shorter administration periods and choose times to take the tissue for histology that permit discrimination of the different phases of neurogenesis. Nevertheless, when proliferation is slow or cells are few, such as in aging studies, it may be necessary to administer BrdU for a longer time to obtain an adequate cell sample size for study.
The retention of BrdU prevents detection of progression into the G 2 phase of cell cycle or the subsequent reentry of that cell into cell cycle (Fig. 1B) . To achieve this degree of temporal discrimination, the examination of endogenous cell cycle proteins is recommended as discussed below. Commonly, a combination of BrdU and endogenous cell cycle markers have been used to calculate cell cycle kinetics. However, the question of cell cycle reentry can be more efficiently addressed by the use of sequential administration of halogenated thymidine analogs. Replacement of the bromo group with iodo or chloro groups results in thymidine analogs that behave the same as BrdU, but whose incorporation can be discriminated immunohistochemically (Vega and Peterson 2005) . Thus, by timing the delivery of each analog administered, it is possible to address questions of cell cycle kinetics, particularly the frequency to reenter the cell cycle in a given cell population (see also Fig. 3 ) (Thomas et al. 2007 ). However, it is critical for the administration of the halogenated thymidine analogs to be given at an equimolar ratio for valid comparisons to be made (Vega and Peterson 2005) .
Possible Artifacts to Thymidine Analog Incorporation
Thymidine analog antibodies have been generated from a variety of species as monoclonal and polyclonal antibodies. Binding of the antibody to labeled DNA requires denaturation of the DNA to remove histones, reduce tertiary DNA structures, or even generate single-stranded DNA. Denaturation is usually performed by exposing cells or tissue to hydrochloric acid, heat, enzymatic digestion, or a combination, depending on the specific antibody and tissue (Kass et al. 2000) . Some suppliers mention in their antibody specifications a possible cross-reactivity with methylated DNA that could lead to unspecific labeling of all nuclei and therefore recommend specific pretreatment. Several conditions can create false-positive signals, producing sporadic reports of neurogenesis in novel regions or in response to injury that demonstrate the need for careful controls in tissue preparation (Grassi Zucconi and Giuditta 2002; Rakic 2002; Kuan et al. 2004 ). The use of alternative fixatives should be compared to results from paraformaldehyde perfusion-fixed tissue, and the use of antigen retrieval treatments should be compared against endogenous cell cycle marker staining to assess the risk of false-positive detection. The specificity of primary antibodies to BrdU-labeled DNA should be determined for each tissue through the use of a short BrdU pulse-chase interval for labeling, with the results compared to coexpression with endogenous cell cycle markers for confirmation. Similar results should be obtained in tissue perfused after a 2-hour BrdU pulse-chase interval (Fig. 1 ). Through these tests, widespread unspecific labeling could be unmasked.
Incorporation of thymidine analogs also can occur during DNA repair, leading to concerns that some observations of cell proliferation could be due to this modest incorporation, rather than transition through S phase. Clearly, complete replication of the genome during cell division will incorporate thymidine analogs to a much higher extent than limited DNA repair (Cooper-Kuhn and Kuhn 2002). Nevertheless, it was suggested that immunohistology could also detect incorporation from DNA repair (Kuan et al. 2004) . Whether this occurs at detectable levels depends largely on the extent of DNA damage and BrdU dose/availability. Cells that undergo extensive DNA repair can reside in lesioned tissue, for example, after radiation or ischemia. Damaged cells can also up-regulate cell cycle markers and even undergo aberrant cell cycle entry, making the distinction between apoptosis and cell cycle entry even more difficult (Busser et al. 1998; Yang et al. 2001) . Although a more recent study suggests that mistaken apoptosis may not be a great concern in the adult brain (Bauer and Patterson 2005) , investigators should still use caution in interpretation. The use of a lower dose of thymidine analog (50 mg/kg for BrdU or equivalent) is recommended to reduce the probability of detecting lower levels of non-S-phase thymidine analog incorporation, particularly as these lower doses are equally effective at detecting proliferation (Burns and Kuan 2005) .
Endogenous Cell Cycle Proteins
Whereas thymidine analog incorporation provides a temporal signature for DNA replication, detection of endogenous cell cycle proteins identifies the population of cells engaged in the process of cell cycle at that time. As illustrated in Figure 1 , a variety of cell cycle proteins have been used to detect separate phases of cell cycle progression (for comprehensive reviews of endogenous proteins in adult neurogenesis, see Eisch and Mandyam 2004, 2007) . The pattern of protein expression provides a valuable tool for examining how changes to the microenvironmental niche might specifically regulate cell proliferation.
Labeling for endogenous cell cycle proteins has an advantage in that only currently cycling cells are detected, whereas with thymidine analog delivery, the event of DNA replication obscures subsequent discrimination of cell cycle activity (unless temporal separation of chlorodeoxyuridine [CldU] and iododeoxyuridine [IdU] probes are used as discussed above). Another practical advantage of endogenous protein detection is in studies where it is not feasible to deliver thymidine analogs, such as in use of available human postmortem tissue. However, caution must be used in equating thymidine analog studies with the use of endogenous protein detection due to the fact that the cell cycle proteins reveal a wider population of cells activated for cell cycle, not all of which may necessarily proceed through DNA replication if held up at an upstream checkpoint.
Lineage Tracking by Retroviral Vectors
Retroviral vectors specifically infect dividing cells, and this property has been used with great success for in vivo delivery of transgenes to proliferating 32--H.G. Kuhn and D.A. Peterson cells in neurogenic niches. Use of fluorescent reporter genes, such as green fluorescent protein (GFP), has revealed the subsequent morphological development and distribution of newly generated cells and has proven to be a useful lineage marker for studies of subsequent lineage commitment. The filling of cells with GFP has enabled specific studies of functional connections of newly generated cells and allowed their identification in slice preparations for studying their electrophysiological maturation and integration (van Praag et al. 2002; Laplagne et al. 2006) . Despite the usefulness of retrovirus-mediated delivery of a fluorescent reporter gene for lineage marker studies, caution should be used as the transfer of fluorescent protein to a postmitotic neuron has been reported following infection of proliferating microglial cells (Ackerman et al. 2006 ).
LINEAGE COMMITMENT
In early studies of adult neurogenesis, detecting coexpression of BrdU with a marker of mature neuronal phenotype was the primary goal for establishing whether or not neurogenesis was occurring. As the field has matured, it has become increasingly important to define more than the final maturation as an endpoint and to address the characterization and regulation of the process. Studies of adult neurogenesis have borrowed from the collection of markers expressed in the developing nervous system and applied these to the postnatal brain. Just as in development, newly generated cells in the adult brain progress through a series of lineage commitment stages prior to the adoption of mature phenotype markers and evidence of function (Kempermann et al. 2004 ). The markers that are presently available are not strictly sequential in their expression but have varying amounts of overlap as lineage commitment proceeds (Fig. 2) . It has also become evident that lineage commitment is indicated prior to terminal exit from cell cycle ( Fig. 2A) . Thus, the early division of adult neurogenesis into distinct proliferation, differentiation, and mature phases has become blurred and is now thought of as a continuum. Although the expression of recognized lineage commitment markers provides a useful construct for our understanding of the process, it is likely that their expression patterns and duration reflect molecular regulatory events that we are only beginning to understand. As such, markers of lineage commitment provide important signposts for organizing data about the regulation of neurogenesis. 
Early Markers of Neuronal Stem Cells
The study of early events in stem cell biology, such as self-renewal and lineage commitment, requires the ability to detect these stem cells with suitable markers. However, for the purpose of specifically detecting neurogenesis, these markers are of limited value, since they can only provide an indication of whether a region is in principle able to generate new neurons. Furthermore, the multipotent character of stem cells makes it unclear to predict to what extent neuronal differentiation will be 34--H.G. Kuhn and D.A. Peterson achieved. Currently, there is no single neuronal stem cell marker that is definitive for neuronal stem cells. The most widely used marker, nestin, is indicative of early neuroectodermal commitment, but it can also be detected in vascular structures. Therefore, the best practices for identifying early markers of neuronal stem cells rely on a combination of otherwise more ubiquitous markers. For example, the combination of glial fibrillary acidic protein (GFAP) and nestin appears to label multipotent cells in neurogenic regions. These cells represent astrocyte-like cells derived from a subset of astrocytes in the subgranular and subventricular zones (Alvarez-Buylla et al. 2002) . These cells share many characteristics with radial glia cells, which act as neuronal progenitors during embryonic development (Malatesta et al. 2000 (Malatesta et al. , 2003 . Neuronal stem cells can also be identified by other markers such as Sox-2 and Pax-6, but as these markers are also expressed widely outside the neurogenic regions, they are not suitable for single use but must be combined with other predictors of neurogenic activity (Stoykova and Gruss 1994; Komitova and Eriksson 2004; Nacher et al. 2005; Baer et al. 2006 ).
Early Markers of Neuronal Lineage Commitment
Detecting cells that have committed to neuronal development has become a very important indicator of ongoing adult neurogenesis. Markers expressed specifically during this phase could be good predictors of ongoing neurogenic activity, provided they fulfill specific criteria. Ideally, neuronal lineage commitment markers need to be transiently expressed only in the neuronally committed cell population, without expression in mature neurons or other brain cell types and without reexpression in neurons under conditions of neuronal injury or regeneration. When sufficiently validated, such endogenous markers could replace BrdU labeling for detecting neurogenesis, especially under conditions that preclude BrdU delivery, such as human tissue. Several such markers have been described in recent years. DCX, a microtubule-associated protein, is currently most widely used as it has been demonstrated to be transiently expressed in neuronal progenitor cells and immature neurons (Brown et al. 2003; Rao and Shetty 2004; Couillard-Despres et al. 2005) . However, reports indicate ectopic expression in neocortical neurons and low-level expression in NG2-positive cells (presumptive glial progenitors), which caution against the use of DCX to determine neurogenesis in brain regions not confirmed by other methods (Nacher et al. 2001 ). The polysialylated form of the neural cell adhesion molecule (PSA-NCAM) and TOAD-64 (also known as TUC-4 and CRMP-4) are other examples. Similar to DCX, transient expression patterns allow labeling of neuronal progenitor cells; however, reports on expression of PSA-NCAM in glial cells and in plasticity of mature neurons make these markers less specific for detection of neurogenesis (Nacher et al. 2000; Seki 2002; Nguyen et al. 2003; Bonfanti 2006) . Another neuronal cytoskeletal protein, βIII-tubulin (also known as Tuj1), is expressed relatively early after neuronal commitment. However, βIII-tubulin is also reported to be expressed in a large number of mature neurons, and its transient expression character is thus unclear. When used in combination with birth-dating by thymidine labeling, most of these early neuronal lineage commitment markers can be reliably used to define early neuronal maturation in studies of adult neurogenesis.
Markers of Maturing Neurons
Once progenitor cells reach maturity, they begin expressing neuronal markers such as neurofilaments, NeuN, calcium-binding proteins, and neurotransmitters. NeuN and neurofilaments can be considered as panneuronal markers; however, NeuN is absent from a few neuronal populations. Fortunately, only one of these cell types, olfactory periglomerular neurons, are generated in adulthood (Mullen et al. 1992; Winner et al. 2002) . Calcium-binding proteins, neurotransmitter enzymes, and neurotransmitters are produced by maturing neurons when the cells become electrophysiologically active. These molecules are specific to subclasses of neurons, and together with BrdU birth-dating, they allow quantification of new neurons. The use of retroviral labeling has also provided a means of confirming the ultrastructural phenotype of new neurons by virtue of cell filling, enabling the identification of dendritic processes bearing mature synapses. Similarly, this technique has been used to validate the electrophysiological maturation of new neurons (van Praag et al. 2002; Laplagne et al. 2006 ).
DETECTION OF MARKER COEXPRESSION

Multiple Labeling Approaches
Detection of proliferating cells using exogenous thymidine analog administration or endogenous cell cycle proteins can provide useful information about quantitative changes in proliferative activity when detected using single-label immunoperoxidase staining. To extract the most 36--H.G. Kuhn and D.A. Peterson information about specific subpopulations that may be represented within the detected population, it is necessary to utilize multiple staining approaches.
Multiple labeling can be accomplished using immunohistochemical staining where the binding of each primary antibody is revealed using a different chromagen. The approach is popular, as the use of immunoperoxidase staining is widespread and protocols can be adapted to include additional chromagens. Imaging can also be performed on a simple bright-field microscope, and thus the material is photostable over time and no additional, expensive fluorescence equipment is required. A number of serious drawbacks with using bright-field microscopy limit its usefulness for studies of multiple labeling. Bright-field microscopy projects focused light through the specimen using diascopic illumination. As a result, cells above and below the focal plane cast shadows that obscure the clear resolution of cells in the focal plane. Given the excessive collapse of tissue section height that occurs in the preparation process, usually in excess of half of the original tissue thickness, cells are packed tightly in the z axis, compounding the problem of resolution and creating difficulties for subsequent demonstrations of three-dimensional colocalization and performing quantitative stereology (for a full discussion, see Peterson 2004) . Discrimination of the chromagen colors may not be possible under these circumstances or if the chromagens coexist in the same cell compartment. Tissue is commonly overstained to achieve high contrast, adding to the difficulty in discriminating overlapping labels.
One common approach to circumvent this problem is to use Nissl staining (also known as cresyl violet or thionin staining) to bind cytoplasmic and nuclear RNA, producing a pattern of labeling in all cells. Experience with the morphological distribution of RNA permits identification of the cell type. Although there is a long heritage of using such chromatic labeling to assign cell phenotype, this approach is not favored for demonstrating cell phenotype in studies of cell lineage now that precise markers are available. For instance, BrdU detection in a cell that appears by Nissl morphology to be a mature neuron is quite weak evidence compared to the use of a specific marker of cell phenotype, such as NeuN, calbindin, and tyrosine hydroxylase. The use of Nissl staining is of no value in the case of cells with early lineage commitment that may not have a remarkable morphology. Finally, Nissl staining is of no use in cases where cell density is high, such as in the granule cell layers of the DG and olfactory bulb (OB).
Multiple immunofluorescence labeling has become the approach of choice to enable clear discrimination of labels. This methodology offers Figure 3 . Detection of neurogenic markers. Detection of neurogenesis is commonly achieved by immunohistochemical detection of newly generated cells labeled with the thymidine analog BrdU (1a) assessed with their coexpression of mature neuronal markers, such as NeuN (1b), or mature glial markers, such as S100β for mature astrocytes (1c). Coexpression can be determined from the amount of signal overlap (1d). Full determination of colocalization requires discrimination of signal colocalization in three dimensions (2a), which can be illustrated by orthogonal projections of a point in space (shown as white crosshairs) with the projected side views in the X-Z an advantage for detecting coexpression due to the ability to separately excite fluorophores and discriminate their emission based on spectral properties. Depending on the properties of the antibodies or dyes available and on suitable instrumentation, investigators can image three to four colors for analysis. In addition to using multiple immunofluorescence to extract additional information about neurogenesis from each section, it is possible to combine this labeling with endogenous expression of fluorescent reporter genes in transgenic mice (Fig. 3) .
Determination of Coexpression in Three Dimensions
Fluorescence microscopy, particularly confocal microscopy, also facilitates the collection of expression data in three-dimensional stacks of images to provide evidence for coexpression in the same or distinct cell compartments. The importance of using exacting standards for identifying coexpression is well-illustrated by early reports in the field of adult neurogenesis that mistakenly report its occurrence in the cerebral cortex, when actually two closely apposed cells gave the appearance of the BrdU label in mature cortical neurons (Fig. 4) . Largely as a result of these missteps, evidence for colocalization now requires well-documented threedimensional colocalization (Kornack and Rakic 2001; Bhardwaj et al. 2006) .
Assessment and quantification of marker coexpression should utilize three-dimensional data sets for the reasons discussed above. It is also good practice to document the three-dimensional data set when presenting (Table 2 ). The most straightforward way to achieve this without the need for specialized software is to represent successive focal planes of a three-dimensional set as a series of panels in a figure (see Fig. 4 ). When such a sequence is presented in combination with a through-projection of the entire data set as a single image, the investigator is able to appreciate the overall coexpression of markers in space while having confidence that the spatial distribution of the signal validates the interpretation of coexpression. A popular alternative to this presentation is the generation of orthogonal projections at a defined coordinate within the three-dimensional data set (see Fig. 3 ). Orthogonal projections are calculated X-Z and Y-Z views (e.g., essentially side views, looking at the image set from "end-on") electronically generated to pass through a particular cell to illustrate colocalization at that spatial reference point. Software to generate orthogonal projections is a feature in the operating software for most confocal microscopes.
Artifacts in Fluorescence Detection
Despite the power of fluorescence detection of neurogenesis, there are two detection artifacts that have the potential to lead to misidentification and misinterpretation of neurogenesis. One of these artifacts is the result of emission from one fluorophore or dye contributing signal to another detection channel as a result of its extended emission spectral profile extending into the emission profile of another signal. This phenomenon Detection and Phenotypic Characterization of Adult Neurogenesis--41 is very closely apposed to a NeuN-positive neuron (red). Note that the cytoplasm of the neuron appears to be indented by the attached satellite cell soma (arrow in 3b). If the satellite cell and neuron are oriented along the z axis, regular fluorescence microscopy will determine colabeling (see 4a), whereas z-stack analysis of confocal images would determine that the BrdU-positive nucleus (in focus in e) does not correspond to the neuronal nucleus in focus (g). Autofluorescence is a particularly difficult artifact in aged rodent tissue and primate tissue. Unstained sections mounted and imaged directly show autofluorescence in the olfactory bulb (OB) demonstrated by excitation illumination at 488 nm resulting in nonspecific emission of autofluorescing particles at 510 nm (green, 5a), 605 nm (red, 5b), and 700 nm (blue, 5c).
Merging all channels of detection shows that the resulting combination of emission detection does not always produce the additive color of white as signal intensity differs between detection channels. The low-power view shown in panel 5a would appear similar following staining for BrdU, and the false-positive autofluorescence would have to be carefully discriminated from true BrdU-positive signal to avoid overcounting.
is commonly called bleed-through and can result in a false-positive interpretation of coexpression. Bleed-through is easily controlled for by choosing fluorophores or dyes with narrow emission spectra and always using sequential collection of each signal, rather than relying on simultaneous collection of all signals. Good microscopy practice dictates that the operator should validate the specificity of each signal being detected and checking in other detection channels for the possibility of bleedthrough (Table 2 ). Sequential image collection may take longer, but the absence of artifacts justifies the extra effort.
Autofluorescence, especially in aging and primate tissue, is another serious artifact that can produce errors in interpretation. The natural accumulation of unprocessed cellular debris produces a broad emission spectrum when excited by a wide range of excitation wavelengths, with lower excitation wavelengths producing stronger emissions. The clumped nature of the autofluorescent emission can appear similar to nonsaturating levels of thymidine analog incorporation. As a result, the danger of misinterpreting autofluorescence as a true signal is greatest when the expected signal distribution is also punctate and primarily in the nucleus or perikaryon, such as with BrdU staining (Fig. 4) . Various approaches have been proposed to quench endogenous autofluorescence prior to tissue staining; however, we have found none of these to be adequate to remove the detection problems. The best practice for imaging aging or primate tissue or tissue following experimental injury, where autofluorescence may be encountered, is to evaluate the extent of emission seen in all channels following excitation with a low wavelength ( Table 2) . Even with sequential 42--H.G. Kuhn and D.A. Peterson Table 2 . Best practices for detecting label coexpression • Use fluorescence labeling when possible for precise discrimination of signal.
• Use appropriate high-numerical-aperture objective lenses for the best axial resolution (i.e., the narrowest depth of field).
• Use appropriate filters for specific fluorescence signal detection.
• Use entire dynamic range of signal detection to avoid oversaturating the image and obscuring coexpression.
• Collect a three-dimensional image stack to fully identify signal distribution within cell compartments.
• Validate that image does not contain signal bleed-through by collecting each channel with separate excitation.
• Validate that apparent colocalization is not autofluorescence by examining if low-wavelength excitation produces emission at longer wavelengths.
collection, it is possible to acquire autofluorescence. Images should be examined for precise spatial coexpression of particles with relatively equal intensity and regard these as possible autofluorescence.
QUANTIFICATION OF NEUROGENESIS
To test hypotheses about changes in neurogenesis, it is necessary to generate reliable numbers that are suitable for statistical evaluation. The determination of cell number in tissue sections was long undertaken in a relatively naive fashion where it was assumed that all cells present could be readily observed and discriminated in a single focal plane. Even with thin sections under conditions of high staining contrast, this approach does not account for sectioning or detection artifacts. When changes in cell number are a major readout of the study results, methodological errors have the potential to seriously misrepresent the study outcome. As a result, the neuroscience community in recent years has increasingly moved to using quantitative approaches described as design-based stereology to reduce the contribution of errors and artifacts in the generation of numbers while at the same time systematically sampling through the entire tissue to obtain a reliable estimate of the total population of cells (Peterson 1999 (Peterson , 2004 Schmitz and Hof 2005) . The production of estimates of all the labeled cells in a structure is a much more biologically relevant parameter than estimates based on a density (area, volume, or per section) that is subject to alteration between experimental conditions. The need to produce three-dimensional stacks of confocal images to accurately assess colocalization (discussed above) only requires careful standardization in sampling parameters to be ideally suited for using stereology (Table 3) . It is important to note here that applying the disector counting principle to confocal image stacks is not, in itself, a proper implementation of stereology without appropriate tissue sampling and should not be described as such in reporting results. The image stacks themselves must be collected in a true systematic random fashion to be properly called stereology. There are some challenges to implementing stereology in studies of adult neurogenesis, primarily due to the low abundance of newly generated cells in some neurogenic regions (particularly the hippocampal DG) and in regions being assessed for response of neural stem cells to injury or other experimental perturbation. As cells in such regions are relatively infrequent and often found in clusters, there has been considerable discussion about the use of stereology under these circumstances. One concern is the uncomfortably high level of within-sample variance produced by the distribution of these cells. In fact, this statistic merely reflects the realities of cell distribution.
Historically, within-sample variance has been used as a guide to assess whether sampling frequency has been adequate. This works well when there is an abundance of cells that are relatively homogeneous in distribution. As a result, within-sample variance statistics are of reduced value in judging suitability of sampling in studies of neurogenesis where cells are in low abundance. Investigators may need to oversample sections under these circumstances. A useful guide to the suitability of sampling can be obtained from determining the between-sample variance of the population estimates for all subjects within an experimental group. Some of this variance calculation will be due to inter-animal variation, some to differences in experimental manipulation if the animals are not naive controls, and the remainder will be due to sampling variance.
Another concern about using stereology to quantify neurogenesis has arisen from the amount of work required to sample relatively rare cell populations. Modifications of existing stereology methods are being devised to further automate this sampling and increase throughput to reduce the amount of work required to perform the sampling while retaining the three-dimensional sampling (using the optical disector probe) needed to avoid methodological errors in counting cells. These higher-throughput methods are currently being developed (D.A. Peterson, pers. comm.) . Kuhn and D.A. Peterson Table 3 . Best practices for quantifying neurogenesis
44--H.G.
• Use appropriate high-numerical-aperture oil immersion objective lenses for the best axial resolution (i.e., the narrowest depth of field).
• Validate that staining exists throughout the mounted section thickness so that there is no "dead zone" in the middle devoid of staining where no cells will be counted even though they may exist there.
• Use design-based stereological sampling to estimate total cell number independent from differences in region or volume between experimental and control conditions. • Determine the thickness of mounted (not cut) tissue for use in calculating results.
• Use careful systematic sampling of the tissue when collecting image stacks to ensure compliance with stereological formulae.
• Confocal image stacks are ready-made for stereological counting, but use guard zones and disector probe counting rules to avoid artifacts and methodological biases.
SUMMARY
Studies of adult neurogenesis have greatly expanded in the last decade, largely as a result of improved tools for detecting and quantifying neurogenesis. Occasions where original interpretations about neurogenesis have had to be reconsidered in light of subsequent reports indicate how careful attention to the strengths and limitations of detection and quantification methods are critical to substantiating study outcomes. Properly used and evaluated, the tools presently available to the research community provide ample resources to advance our understanding of the regulation of adult neurogenesis.
